Model 432-01 Biopore Implantable Pacing Lead
by Intermedics, Inc. 510(k)
Active
510(k) K862053
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK862053 | Date19 Sep 1986 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Model 432-01 Biopore Implantable Pacing Lead is a Permanent Pacemaker Electrode, classified as a Class III device under FDA regulations. This device is implanted within the heart to deliver controlled electrical impulses, ensuring proper cardiac rhythm regulation in patients requiring pacing support. Its biopore design promotes enhanced tissue integration and stability within cardiac tissue, improving long-term performance and reducing complications.
The lead is supplied sterile and intended for single-use implantation by qualified healthcare professionals in clinical settings such as cardiac catheterization labs or operating rooms. It adheres to FDA clearance under 510(k) K862053, with a decision classification of Substantially Equivalent to predicate devices. No specific MRI safety information is provided, and storage conditions are not detailed in the available data. The device is regulated under FDA regulation number 870.3680, with registration numbers and FEI numbers listed for tracking.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Model 432-01 Biopore Implantable Pacing Lead, and how does its design improve patient outcomes?
The Model 432-01 Biopore Implantable Pacing Lead is designed to deliver controlled electrical impulses to regulate cardiac rhythm in patients requiring pacing support. Its biopore design promotes better tissue integration and stability within the heart, which helps reduce complications and improves long-term performance compared to standard leads.
Is the Model 432-01 Biopore Implantable Pacing Lead intended for reuse, or is it meant for single-use implantation?
The device is explicitly supplied sterile and intended for single-use implantation only. It must be used once and discarded, ensuring patient safety and sterility in clinical settings like cardiac catheterization labs or operating rooms.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its safety and equivalence?
The Model 432-01 received FDA clearance under a 510(k) submission (K862053), classified as Substantially Equivalent (SESE) to predicate devices. This means the FDA determined it has the same intended use and technological characteristics as a previously cleared lead, ensuring it meets regulatory standards for safety and effectiveness.
Where and how should this device be stored, and are there any special handling instructions provided?
The available data does not specify storage conditions for the Model 432-01 Biopore Implantable Pacing Lead. However, as a sterile, single-use device, it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures until use, following standard medical device storage protocols.
Does this device have any known limitations regarding MRI compatibility, and what should clinicians consider before use?
The data does not provide specific MRI safety information for the Model 432-01 Biopore Implantable Pacing Lead. Clinicians should exercise caution when considering MRI procedures for patients with this device, as implantable leads may pose risks in magnetic fields. Consulting the manufacturer’s latest guidelines or safety data is strongly advised.